Suchergebnisse - "Igarashi, Atsuyuki"

PubPharm (111)

1

Efficacy and safety of nemolizumab and topical corticosteroids for prurigo nodularis : Results from a randomised, double-blind, placebo-controlled, phase II/III clinical study in patients aged ≥13 years

enthalten in: The British journal of dermatology | 2024

von Yokozeki, H. | Murota, H. | Matsumura, T. | +72

2

Safety, efficacy, and pharmacokinetics of delgocitinib ointment in infants with atopic dermatitis : A phase 3, open-label, and long-term study

enthalten in: Allergology international : official journal of the Japanese Society of Allergology | 2024

von Nakagawa, H. | Igarashi, A. | Saeki, H. | +4

3

Efficacy and safety of nemolizumab in paediatric patients aged 6-12 years with atopic dermatitis with moderate-to-severe pruritus : results from a phase III, randomized, double-blind, placebo-controlled, multicentre study

enthalten in: The British journal of dermatology | 2023

von Igarashi, A. | Katsunuma, T. | Matsumura, T. | +43

CommentIn: Br J Dermatol. 2023 Sep 02;:. - PMID 37658936

4

English version of Japanese guidance for biologics in treating atopic dermatitis

enthalten in: The Journal of dermatology | 2023

von Saeki, H. | Akiyama, M. | Abe, M. | +10

5

English version of Japanese guidance for the use of oral Janus kinase inhibitors (JAK1 and TYK2 inhibitors) in the treatments of psoriasis

enthalten in: The Journal of dermatology | 2023

von Saeki, H. | Mabuchi, T. | Asahina, A. | +12

6

Real-world safety and effectiveness of omalizumab in Japanese patients with chronic spontaneous urticaria : A post-marketing surveillance study

enthalten in: Allergology international : official journal of the Japanese Society of Allergology | 2023

von Hide, M. | Fukunaga, A. | Suzuki, T. | +5

7

Bimekizumab Efficacy and Safety in Japanese Patients with Plaque Psoriasis in BE VIVID : A Phase 3, Ustekinumab and Placebo-Controlled Study

enthalten in: Dermatology and therapy | 2023

von Asahina, A. | Okubo, Y. | Morita, A. | +9

8

English version of Japanese guidance for use of biologics for psoriasis (the 2022 version)

enthalten in: The Journal of dermatology | 2023

von Saeki, H. | Mabuchi, T. | Asahina, A. | +12

9

Bimekizumab Efficacy and Safety in Japanese Patients with Plaque Psoriasis in BE VIVID: A Phase 3, Ustekinumab and Placebo-Controlled Study

enthalten in: Dermatology and therapy | 2023

von Asahina, A. | Okubo, Y. | Morita, A. | +9

10

Bimekizumab Efficacy and Safety in Japanese Patients with Plaque Psoriasis in BE VIVID: A Phase 3, Ustekinumab and Placebo-Controlled Study

enthalten in: Dermatology and therapy | 2023

von Asahina, A. | Okubo, Y. | Morita, A. | +9

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[12]